UC San Diego Health Moores Cancer Center
@UCSDCancer
NCI-designated & Comprehensive. Research, clinical trials, transformative care, survivorship, public-policy changing discoveries. #DeliveringDiscoveries
🔬 Researchers at @UCSDMedSchool have identified a gene signature that could serve as an early warning sign for pancreatic cancer Understanding the protein STAT3 could help physicians identify patients with a higher risk of developing aggressive cancers, and work to develop…

Understanding tumor blood supply is key to developing treatments to stop their growth. To track blood flow and test drug efficacy, researchers are turning to a zebrafish cancer model 🐟 🔬 A research team including MCC member David Traver, PhD, used a high-tech, non-invasive…

Lyudmila Bazhenova, MD, is part of a team of researchers working to enhance clinical practice in oncology 🩺 Dr. Bazhenova and colleagues published new living guidelines for non-small cell lung cancer in @JCO_ASCO this past week, assessing recommendations for patients based on…

🧬 Researchers have found that tiny RNA fragments have a big impact on RNA autophagy, a process that protects kidney cells from injury. This study of hypoxia-induced RNA, conducted by Louise C. Laurent, MD, PhD, and colleagues, might reveal key ways to maintain kidney health…

💡 With a $1 million grant from @TheVFoundation, Moores Cancer Center and @salkinstitute are changing the course of pancreatic cancer treatment. Dr. Gregory Botta is collaborating with Salk's Diana Hargreaves to improve immunotherapy treatments, identify potential biomarkers and…

Save the Date for a weekend unlike any other! 🌊 Join us for Legends of Science and Surfing September 12 and 13, a two-day event uniting leaders in science and surfing for a weekend of innovation, collaboration and community. Learn more 🔗 mcclegends.ucsd.edu

In a new 20+ year study published in @AGA_CGH, researchers revealed key methods of treatment for H. pylori infections 💡 Shailja Shah, MD, MPH, and colleagues found that two 14-day antibiotic combinations were most effective, achieving a nearly 90% success rate. Read more:…

Sarcomas often grow silently and can be mistaken for harmless lumps. At #UCSDHealth, our team of experts offer leading-edge diagnostics, advanced treatments & personalized care. ✅ Trust your instincts ✅ Get unusual lumps checked ✅ Learn how we can help: health.ucsd.edu/care/cancer/ca…
TULSA is a groundbreaking, minimally invasive outpatient procedure redefining prostate cancer treatment. ❤️🩹 This innovative treatment enables patients like Mark Nicholson to avoid traditionally invasive procedures and maintain quality of life. As the first and only hospital in…
Join us in congratulating Yu-Wei Chen, MD, MS, a new recipient of a @kidneycan Merit Award! 🏆 Dr. Chen received the award for Highest Ranked Clinical Research from a Faculty Member, underscoring the excellence of his work investigating HIF-2a RNA expression in clear cell renal…

In honor of Cancer Awareness Month, @MadameSurgeon sat down with @SDbusiness to discuss Moores Cancer Center's role in the fight against cancer. 🎗️ Learn more about exciting advancements in cancer treatment and care, and how industry partnerships fuel powerful innovation:…

Cytoscape Web is here — bringing with it improved connectivity, accessibility and collaboration. 💡 A team of researchers, including MCC's @TreyIdeker and Dexter Pratt, have introduced a new way to analyze biological networks and adapt to computational challenges in the field.…

🔬 Researchers have discovered a key biomarker that might change the way Langerhans Cell Histiocytosis (LCH) is treated. Deborah Schiff, MD, and colleagues found that patients with a specific mutation were much less likely to respond to first-line chemotherapy, and proposed new…

Get to know Dan Kaufman, MD, PhD, in this edition of #ResearcherSpotlight 👨🔬 🌟 Learn more about his career, and explore his research in blood cancers and recent innovations in clinical applications for cancer treatment: bit.ly/3XDvbFm

New results from a clinical trial revealed insights into the future of precision medicine treatments for fatty liver disease 💡 In a paper published in @HEP_Journal, Rohit Loomba, MD, and colleagues found that AZD2693 effectively reduced liver fat and inflammation in patients…

Every July, we honor Sarcoma Awareness Month 🎗️💛 Dr. @JasonSicklick is a surgical oncologist who specializes in treating sarcomas. Hear more from him about the outstanding cancer care at @UCSDHealth: youtube.com/watch?v=kS4BX6…
Researchers at @UCSDPharmacy are exploring how GRK "barcodes" influence cell signaling 🧬 In a new paper published in @Nature, Tracy M. Handel, PhD, and colleagues revealed ways these "barcodes" could inform new therapeutic strategies to disrupt cancer signaling. 🔗 Read More:…

Congratulations to Alice L. Yu, MD, PhD, on receiving a Lifetime Achievement Award from the Advances in Neuroblastoma Research Association (ANRA) 🏆 🌟 This award recognizes Dr. Yu's groundbreaking work on an anti-GD2 antibody therapy that has transformed the landscape of…

Happy 4th of July! 🗽🌟 Wishing everyone a safe and happy Independence Day weekend.

Lung cancer is on the rise in never-smokers. A new study published in @Nature gave insights into what might be driving this significant increase 💡 Ludmil Alexandrov, PhD, and colleagues found genomic links between exposure to environmental pollution and the development of lung…
